Cargando…

ATM c.7570G>C is a high‐risk allele for breast cancer

ATM is generally described as a moderate‐risk breast cancer susceptibility gene. However, some of ATM variants might encounter higher risk. ATM c.7570G>C, p.Ala2524Pro, (rs769142993) is a pathogenic Finnish founder variant causative for recessively inherited ataxia‐telangiectasia. At cellular lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Kankuri‐Tammilehto, Minna, Tervasmäki, Anna, Kraatari‐Tiri, Minna, Rahikkala, Elisa, Pylkäs, Katri, Kuismin, Outi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092731/
https://www.ncbi.nlm.nih.gov/pubmed/36161273
http://dx.doi.org/10.1002/ijc.34305
_version_ 1785023419002126336
author Kankuri‐Tammilehto, Minna
Tervasmäki, Anna
Kraatari‐Tiri, Minna
Rahikkala, Elisa
Pylkäs, Katri
Kuismin, Outi
author_facet Kankuri‐Tammilehto, Minna
Tervasmäki, Anna
Kraatari‐Tiri, Minna
Rahikkala, Elisa
Pylkäs, Katri
Kuismin, Outi
author_sort Kankuri‐Tammilehto, Minna
collection PubMed
description ATM is generally described as a moderate‐risk breast cancer susceptibility gene. However, some of ATM variants might encounter higher risk. ATM c.7570G>C, p.Ala2524Pro, (rs769142993) is a pathogenic Finnish founder variant causative for recessively inherited ataxia‐telangiectasia. At cellular level, it has been reported to have a dominant‐negative effect. ATM c.7570G>C has recurrently been described in Finnish breast cancer families and unselected case cohorts collected from different parts of the country, but the rarity of the allele (MAF 0.0002772 in Finns) and lack of confirming segregation analyses have prevented any conclusive risk estimates. Here, we describe seven families from genetic counseling units with ATM c.7570G>C variant showing co‐segregation with breast cancer. Further analysis of the unselected breast cancer cohort from Northern Finland (n = 1822), a geographical region previously indicated to have enrichment of the variant, demonstrated that c.7570G>C significantly associates with breast cancer, and the risk is estimated as high (odds ratio [OR] = 8.5, 95% confidence interval [CI] = 1.04‐62.46, P = .018). Altogether, these results place ATM c.7570G>C variant among the high‐risk alleles for breast cancer, which should be taken into consideration in genetic counseling.
format Online
Article
Text
id pubmed-10092731
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-100927312023-04-13 ATM c.7570G>C is a high‐risk allele for breast cancer Kankuri‐Tammilehto, Minna Tervasmäki, Anna Kraatari‐Tiri, Minna Rahikkala, Elisa Pylkäs, Katri Kuismin, Outi Int J Cancer Cancer Genetics and Epigenetics ATM is generally described as a moderate‐risk breast cancer susceptibility gene. However, some of ATM variants might encounter higher risk. ATM c.7570G>C, p.Ala2524Pro, (rs769142993) is a pathogenic Finnish founder variant causative for recessively inherited ataxia‐telangiectasia. At cellular level, it has been reported to have a dominant‐negative effect. ATM c.7570G>C has recurrently been described in Finnish breast cancer families and unselected case cohorts collected from different parts of the country, but the rarity of the allele (MAF 0.0002772 in Finns) and lack of confirming segregation analyses have prevented any conclusive risk estimates. Here, we describe seven families from genetic counseling units with ATM c.7570G>C variant showing co‐segregation with breast cancer. Further analysis of the unselected breast cancer cohort from Northern Finland (n = 1822), a geographical region previously indicated to have enrichment of the variant, demonstrated that c.7570G>C significantly associates with breast cancer, and the risk is estimated as high (odds ratio [OR] = 8.5, 95% confidence interval [CI] = 1.04‐62.46, P = .018). Altogether, these results place ATM c.7570G>C variant among the high‐risk alleles for breast cancer, which should be taken into consideration in genetic counseling. John Wiley & Sons, Inc. 2022-10-06 2023-02-01 /pmc/articles/PMC10092731/ /pubmed/36161273 http://dx.doi.org/10.1002/ijc.34305 Text en © 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Cancer Genetics and Epigenetics
Kankuri‐Tammilehto, Minna
Tervasmäki, Anna
Kraatari‐Tiri, Minna
Rahikkala, Elisa
Pylkäs, Katri
Kuismin, Outi
ATM c.7570G>C is a high‐risk allele for breast cancer
title ATM c.7570G>C is a high‐risk allele for breast cancer
title_full ATM c.7570G>C is a high‐risk allele for breast cancer
title_fullStr ATM c.7570G>C is a high‐risk allele for breast cancer
title_full_unstemmed ATM c.7570G>C is a high‐risk allele for breast cancer
title_short ATM c.7570G>C is a high‐risk allele for breast cancer
title_sort atm c.7570g>c is a high‐risk allele for breast cancer
topic Cancer Genetics and Epigenetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092731/
https://www.ncbi.nlm.nih.gov/pubmed/36161273
http://dx.doi.org/10.1002/ijc.34305
work_keys_str_mv AT kankuritammilehtominna atmc7570gcisahighriskalleleforbreastcancer
AT tervasmakianna atmc7570gcisahighriskalleleforbreastcancer
AT kraataritiriminna atmc7570gcisahighriskalleleforbreastcancer
AT rahikkalaelisa atmc7570gcisahighriskalleleforbreastcancer
AT pylkaskatri atmc7570gcisahighriskalleleforbreastcancer
AT kuisminouti atmc7570gcisahighriskalleleforbreastcancer